XETRA - Delayed Quote EUR

Geratherm Medical AG (GME.DE)

Compare
3.5200
-0.1400
(-3.83%)
As of 11:51:40 AM GMT+1. Market Open.
Loading Chart for GME.DE
DELL
  • Previous Close 3.6600
  • Open 3.5800
  • Bid 3.5000 x 14100
  • Ask 5.0000 x 69700
  • Day's Range 3.5200 - 3.7200
  • 52 Week Range 2.5600 - 5.7000
  • Volume 30
  • Avg. Volume 1,358
  • Market Cap (intraday) 19.05M
  • Beta (5Y Monthly) 0.11
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1800
  • Earnings Date --
  • Forward Dividend & Yield 0.10 (2.73%)
  • Ex-Dividend Date Aug 19, 2024
  • 1y Target Est 7.00

Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors. The Respiratory segment develops and manufactures products primarily for pulmonary and cardiopulmonary function diagnostics. The Medical Warming Systems segment offers MRI-compatible incubators for premature babies under the LMT brand. The Cardio/Stroke segment offers stroke risk analysis products for the detection of atrial fibrillation. The company markets its products through pharmacies, hospitals, and clinics. It exports its products to approximately 60 countries. The company was founded in 1990 and is headquartered in Geschwenda, Germany.

www.geratherm.com

179

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GME.DE

View More

Performance Overview: GME.DE

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

GME.DE
0.57%
DAX P
1.94%

1-Year Return

GME.DE
34.32%
DAX P
21.61%

3-Year Return

GME.DE
54.76%
DAX P
27.26%

5-Year Return

GME.DE
51.60%
DAX P
50.39%

Compare To: GME.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GME.DE

View More

Valuation Measures

As of 1/9/2025
  • Market Cap

    19.81M

  • Enterprise Value

    20.05M

  • Trailing P/E

    18.68

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.05

  • Price/Book (mrq)

    0.94

  • Enterprise Value/Revenue

    1.06

  • Enterprise Value/EBITDA

    13.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.54%

  • Return on Assets (ttm)

    -0.51%

  • Return on Equity (ttm)

    -4.54%

  • Revenue (ttm)

    18.31M

  • Net Income Avi to Common (ttm)

    -830.5k

  • Diluted EPS (ttm)

    -0.1800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.33M

  • Total Debt/Equity (mrq)

    30.76%

  • Levered Free Cash Flow (ttm)

    -650.79k

Research Analysis: GME.DE

View More

People Also Watch